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BACKGROUND: Cognitive-behavioral stress management interventions are associated with improved psychological well-being for cancer survivors. The availability of, access to, and outreach of these in-person interventions are limited, however. The current study, therefore, evaluated the efficacy of StressProffen, a digital application (app)–based stress management intervention for cancer survivors, in a
12-month randomized controlled trial. METHODS: Cancer survivors 1 year or less after their treatment (N = 172) were randomized to the
StressProffen intervention (n = 84) or a usual-care control group (n = 88). The intervention was delivered in a simple blended care model:
1) 1 in-person introduction session, 2) 10 app-based cognitive-behavioral stress management modules, and 3) 2 follow-up phone calls.
Stress (Perceived Stress Scale), anxiety and depression (Hospital Anxiety and Depression Scale), self-regulatory fatigue (Self-Regulatory
Fatigue 18), and health-related quality of life (HRQOL; RAND-36) were examined at the baseline and at 6 and 12 months. Generalized
linear models for repeated measures were fitted to compare effects over time. RESULTS: Participants were mainly female (82%), had
a mean age of 52 years (standard deviation, 11.3 years; range, 20-78 years), and had a variety of cancer types (mostly breast cancer
[48%]). Over the 12-month study time, the intervention group reported significantly decreased stress (P < .001), depression (P = .003),
and self-regulatory fatigue (P = .002) as well as improved HRQOL (for 6 of 8 domains, P ≤ .015) in comparison with controls. The largest
favored effects for the intervention group were observed at 6 months: stress (estimated mean difference [MD], –5.1; P < .001), anxiety
(MD, –1.4; P = .015), depression (MD, –2.1; P < .001), self-regulatory fatigue (MD, –4.9; P < .001), and HRQOL (7 of 8 domains; P ≤ .037).
CONCLUSIONS: Digital stress management interventions such as StressProffen have the potential to extend the outreach of psychological interventions and provide easily available and effective psychosocial support for cancer survivors. Cancer 2021;0:1-10. © 2021 The
Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society This is an open access article under the terms
of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided
the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
KEYWORDS: cancer survivors, cognitive behavioral, electronic health (eHealth), mobile applications, psychological distress, psycho-
oncology, stress management.

INTRODUCTION
Cancer diagnosis and treatment are associated with physical and psychosocial challenges, including discomfort, fatigue,
pain, stress, distress, worry, anxiety, and depression.1-3 Quality of life (QOL)1-6 and the capacity to control or alter
(ie, self-regulate) thoughts, feelings, and behavior7,8 are often also affected, and coping during and after cancer can be
challenging.3,5,8,9
Psychosocial Interventions for Stress Management and Coping in Cancer

Psychosocial interventions aiming to support stress management and coping have for decades been shown to promote
well-being, including improved QOL and reduced stress, distress, anxiety, and depression for cancer survivors.2,4,5,10-15
There are also some indications that the positive impact of such interventions may last for more than 10 years.16
Access barriers to in-person psychological interventions exist, however; they include availability, the geographical
distance from the intervention site, costs/limited insurance coverage, and cancer survivors not feeling well enough or
comfortable enough to participate in in-person sessions.5,15 In light of continued findings that cancer survivors have
many unmet needs, including needs for psychosocial support and care,5,17 health care delivery methods with higher
accessibility and outreach are needed.
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Digital Psychosocial Interventions for Stress
Management in Cancer

Digital solutions in the form of electronic health (eHealth)
interventions have the potential to enhance the delivery of
health care and psychosocial support to cancer survivors.
However, published results from randomized controlled
trials (RCTs) testing psychosocial eHealth interventions
for cancer survivors are mixed and inconclusive.18-22
Examining these findings, researchers have pointed to a
need for eHealth interventions for cancer survivors to be
theoretically based; to have significant involvement from
end users (ie, cancer survivors) and other key stakeholders
(eg, health care providers) during the design and development phases; and to include high-quality outcome assessments, larger sample sizes, and longer follow-up periods
to establish efficacy.19,20,22
StressProffen: A Digital Stress Management
Intervention for Cancer Survivors

In response to identified challenges with eHealth interventions in cancer, the current research team designed
and developed StressProffen, an application (app)-based
stress management intervention program in support of
cancer survivors.23,24 StressProffen combines elements
from well-known cognitive-behavioral stress management
strategies4,12,13 and was designed and developed according
to user-centered design methods with close collaborations
between researchers, cancer survivors, health care providers (eg, psychosocial oncologists), and eHealth experts.23
In line with recommendations to certify the feasibility of
complex medical interventions,25 a feasibility pilot study
testing StressProffen revealed positive acceptability, usability, and feasibility, with positive indications related
to decreased stress, anxiety, and self-regulatory fatigue as
well as improved health-related quality of life (HRQOL)
in cancer survivors.24
The initial RCT evaluation of the program (ie, at
3 months) showed significant pre-
post between-
group
differences, with cancer survivors who received StressProffen
reporting decreased stress and improved HRQOL in comparison with usual-care controls.26 There was also a decrease in anxiety and depression in favor of the intervention
group, although this was not statistically significant. Effect
sizes in the 3-month evaluation were generally small, however, with large data variability, which may have contributed to this.26 Also, although a 58% completion rate (ie,
at least 7 of 10 modules26) is considered above average for
eHealth interventions,27 it is possible that 3 months was
not enough time for the participating cancer survivors to

2

complete the intervention. The current study examined
longer term results from the RCT and evaluated the efficacy
of the StressProffen intervention program over a 12-month
period. It was hypothesized that participants receiving the
StressProffen intervention, compared with participants in
a usual-care control group, would 6 and 12 months after
the intervention initiation experience decreased perceived
stress (the primary outcome) and decreased anxiety, depression, and self-regulatory fatigue and improved HRQOL
(all secondary outcomes).
MATERIALS AND METHODS
Design and Participants

In this RCT, participants (ie, cancer survivors) were assigned to either 1) the app-based StressProffen stress management intervention or 2) a usual-care control group and
were followed for 12 months.
Patients diagnosed with any type or stage of cancer were recruited at a major medical center in Northern
Europe or through social media from June 2017 to July
2019. The eligibility criteria were 1) currently or recently
receiving cancer treatment (ie, ≤1 year after the completion of hospital treatment); 2) being 18 years old or older;
3) being able to speak, read, and understand Norwegian;
4) having access to a smartphone or tablet; and 5) being
able and willing to attend 1 in-person introduction session. See also Børøsund and colleagues26 for additional
details on the study methodology.
The study was approved by the Regional Committee
for Medical and Health Research Ethics (2016/14369)
and the Hospital Privacy Protection Committee
(2015/10204) and was registered with ClinicalTrials.gov
(NCT02939612).
Study Procedure

Patients were informed about the study via medical
center social media and/or outpatient clinics/radiotherapy units, and they could request or self-initiate contact
with the study team if interested. Participants provided
written informed consent and completed baseline study
questionnaires/outcome measures before randomization.
Computerized randomization allocated study arms on a
1:1 basis (block size, 10) with stratification by gender and
diagnosis (ie, breast cancer vs all other cancer diagnoses
on the basis of pilot-study findings).24
All outcome measures and program use data were
collected electronically through a secure server using an
encrypted connection. Participants completed outcome
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Figure 1. Examples of StressProffen screenshots.

measures at the baseline and at 3 (reported elsewhere),26
6, and 12 months.
The StressProffen Intervention

In a simple blended care delivery model, the intervention
group received the following: 1) an in-person introduction session with study personnel, 2) 10 app-based stress
management modules (ie, StressProffen), and 3) followup phone calls 2 to 3 and 6 to 7 weeks after the introduction session. The introduction session was structured and
served the dual purpose of introducing participants to the
stress management concept1,10,12 and helping participants
to download and get started with the program.
The StressProffen program contains 10 modules
with cognitive-behavioral and stress management educational material and exercises: 1) What is Stress; 2) Stress,
QOL, and Planning; 3) Thoughts, Feelings, and Self-
Care; 4) Mindfulness, Thought Challenging, and Guided
Imagery; 5) Stress and Coping; 6) Social Support, Humor,
and Meditation; 7) Anger Management and Conflict
Style Awareness; 8) Assertiveness and Communication;
9) Health Behaviors and Setting Goals; and 10) Review
and Summary.23 See Figure 1 for examples of program
screenshots. For more details about the content, development, and pilot testing of StressProffen, see Børøsund and
colleagues.23,24
Participants were encouraged to complete all 10
modules and to practice the content to become well acquainted with the material. The follow-up phone calls
Cancer  
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were conducted by study personnel, structured, and included questions related to program impression and ease
of use.
Data Collection and Outcome Measures

A study-specific self-report questionnaire collected demographic, disease, and treatment information at the baseline. Comorbidity was measured at the baseline with the
Self-
Administered Comorbidity Questionnaire,28 with
total scores ranging from 0 to 57 and higher scores indicating a more severe comorbidity profile.
Psychosocial Outcome Measures
Primary outcome

Perceived stress was measured by the Perceived Stress
Scale, a 14-item scale measuring feelings and thoughts
over the last month.29 Items are rated on a 5-point Likert
scale ranging from “never” (0) to “very often” (4). Total
scores range from 0 to 56, with higher scores indicating higher perceived stress. Because it is not a diagnostic
measure, the Perceived Stress Scale has no cutoff scores
(ie, scores are labeled low, moderate, or high).
Secondary outcomes

Anxiety and depression were measured with the Hospital
Anxiety and Depression Scale,30 a 14-item measure of
anxiety and depression, with 7 items measuring each
subscale. Items are rated on a 4-point scale (0-3), with
total scores ranging from 0 to 42 and with higher scores
3
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indicating higher anxiety/depression. Score ranges are <8
(nonclinical), 8 to 11 (indicating the presence of anxiety/
depression), and >11 (anxiety/depression). Nevertheless,
there are some indications suggesting that these cutoff
levels are too high for patients with cancer, and this may
result in underrecognition of distress.31
Self-regulatory fatigue was measured with the Self-
Regulatory Fatigue 18 (SRF-18), an 18-item self-report
scale gauging the capacity to regulate cognitive, emotional, and behavioral components of self-regulation.32
The SRF-
18 contains 8 positively phrased items (eg,
“I have no trouble making decisions”) and 10 negatively
phrased items (eg, “I experience uncontrollable temper
outbursts”). Items are scored on a 5-point Likert scale (1-5),
with total scores ranging from 18 to 90 and with higher
scores reflecting higher self-regulatory fatigue. The SRF-
18 has acceptable internal consistency and reliability.32
HRQOL was measured with the 36-
Item Short
Form Health Survey (RAND-36 version),33,34 a 36-item
measure of physical, role, emotional, cognitive, and social function as well as physical health and general and
global health/HRQOL. Subscale scores range from 0
to 100, with lower scores indicating higher disability
(0 = maximum disability, 100 = no disability). A mean of
50 is generally considered normative for all subscales. The
normative mean for the general Norwegian population
may, however, be somewhat higher.35
Program Use

Data related to program use (ie, app progress/activity)
were extracted from user logs automatically collected and
stored on a secure research server.
Statistical Analyses

Baseline characteristics are summarized as means and
standard deviations for normally distributed variables and
as medians and ranges for variables with skewed distributions. Categorical data are presented as counts and percentages. For the analysis of between-group differences
in outcome measurements, generalized linear models
(GLMs) for repeated measures were fitted. To account
for statistical dependencies as each individual was measured several times and time spans between the completed
measurements varied, an unstructured covariance matrix
was used to model variances. Models for each outcome
consisted of 3 covariates: measurement (time), group, and
interaction term (ie, time and group). All measured time
points (ie, for outcome variables) were considered, and
the GLM approach was, therefore, adjusted for baseline
differences.
4

Because no statistically significant differences were
observed between the intervention group and the usual-
care control group in demographic-and disease-related
variables at the baseline, no covariates were included
in the GLMs. Outcome analyses were conducted with
intention-to-treat analyses; all participants in each group
were included independently of how much they had used
the intervention. Between-group differences were computed as the intervention group change from the baseline
to 6 and 12 months minus the control group change from
the baseline.
Participants completing at least 70% of the modules (7 of 10) were defined as program completers.24,26
Exploratory subanalyses for the intervention group only,
using GLMs, were performed to detect potential differences in outcomes between intervention completers and
noncompleters.
P values < .05 were considered statistically significant. Statistical analyses were completed with the
Statistical Package for the Social Sciences (release 27;
SPSS, Inc, Chicago, Illinois) and Stata (version 16).
RESULTS
Sample Description

Among the 175 randomized participants, 3 intervention
group assignees were unable to attend the in-person introduction session because of disease progression. The size of
the final study sample was, therefore, 172. See Figure 2
for recruitment and retention details. Most participants
were recruited by medical center clinic staff (102 of 172;
59%); the remainder were recruited through social media.
The mean age at inclusion was 52 years (standard
deviation, 11.3 years; range, 20-
78 years). The most
common cancer type reported was breast cancer (48%).
Most participants were female (82%), were married or
cohabitating (70%), reported having a university/college
education (81%), and were currently receiving sick leave/
disability benefits (70%). See Table 1 for details.
Between-Group Differences

Including measurements from all time points in the
model showed statistically significant reductions in perceived stress, depression, and self-regulatory fatigue and
improvements in 6 of 8 HRQOL domains over the
12-month study period for the StressProffen intervention
group in comparison with the usual-care control group.
See Table 2 and Figure 3 for details.
For all outcome measures, the largest intervention
effects in favor of the intervention group were observed
Cancer  

Month 0, 2021

Digital Stress Management in Cancer/Børøsund et al

Figure 2. Participant trial flow chart.

at 6 months. Between-group changes from the baseline to
6 months were statistically significant and showed that
the intervention group improved on perceived stress,
anxiety, depression, self-regulatory fatigue, and 7 of 8
HRQOL domains in comparison with the usual-
care
control group. See Table 2 for details.
Program Use

Of the 84 participants in the intervention group, 57
(68%) completed at least 7 of the 10 modules within
the 12-month study period. Thirty-nine (46%) completed all 10 modules. There were no significant differences in outcomes between intervention completers
(ie, ≥7 modules) and noncompleters (ie, ≤6 modules).
Participants used the program a median of 17.5 times
(range, 3-170 times), and the median time from first
Cancer  
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use to last use was 137 days (range, 10-365 days). At
6 months, 40% (34 of 84) still used the program. This
declined to 21% (18 of 84) at 9 months and 12%
(10 of 84) at 11 months.
DISCUSSION
The current study was aimed at evaluating the efficacy
of StressProffen,23,24,26 a digital cognitive-
behavioral
stress management intervention for cancer survivors.
The findings demonstrate a significant positive impact
for the intervention group compared with usual-care
controls, with between-group differences assessed over
12 months showing significant reductions in perceived
stress (ie, the primary outcome) and significant reductions in depression and self-regulatory fatigue and
5
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TABLE 1. Baseline Self-Reported
Sociodemographic and Disease-Related Measures
(N = 172)

Characteristic
Age, mean (SD), y
Gender, No. (%)
Female
Male
Marital status, No. (%)
Married/cohabitating
Single/divorced
Education, No. (%)
Elementary/high school
University/college for ≤4 y
University/college for >4 y
Household annual income,
No. (%)a
<€40,000
>€40,000-€60,000
>€60,000-€80,000
>€80,000-€100,000
>€100,000
Employment status, No. (%)b
Full-time/part-time work
Sick leave/disability benefits
Retired/other
Treatment, No. (%)c
Surgery
Chemotherapy
Hormone therapy
Radiation
Immune therapy
Other
Diagnosis, No. (%)c
Breast cancer
Brain cancer
Prostate cancer
Other
Metastases, No. (%)
Months since diagnosis, median
(range)
Comorbidity, median (range)

Intervention
Group
(n = 84)

Control
Group
(n = 88)

51.7 (10.5)

52.3 (12.0)

69 (82)
15 (18)

72 (82)
16 (18)

56 (67)
28 (33)

64 (73)
24 (27)

17 (20)
29 (35)
38 (45)

16 (18)
31 (35)
41 (47)

P
.725
.956

.387

.943

.629
9 (11)
15 (18)
5 (6)
17 (20)
38 (45)

9 (10)
17 (19)
11 (13)
14 (16)
37 (42)

18 (21)
61 (73)
5 (6)

18 (21)
59 (67)
11 (13)

66 (79)
46 (55)
21 (25)
34 (41)
8 (10)
10 (12)

60 (68)
56 (64)
23 (26)
40 (46)
10 (11)
14 (16)

.124
.236
.864
.519
.694
.449

39 (46)
9 (11)
6 (7)
30 (36)
12 (14)
7.0 (0.25-120)

44 (50)
4 (5)
4 (5)
36 (41)
11 (13)
8.5
(0.25-240)
3.0 (0-17)

.639
.126
.467
.484
.731
.183

.334

3.0 (0-20)

.467

Abbreviation: SD, standard deviation.
a
€1 is approximately US $1.2 or approximately 10 Norwegian kroner (spring
2021).
b
Percentages do not add up to 100 because of rounding.
c
Participants could have received several treatments.

significant improvements in HRQOL (ie, the secondary outcomes).
Psychosocial interventions can support stress management and coping for cancer survivors,2,4,5,10-16 but
access barriers to such in-person interventions exist.5,15
Findings from the use of StressProffen in the current
study, therefore, provide great promise for digital solutions as supplements or alternatives to in-person psychosocial health care for cancer survivors. Even though
the findings were statistically significant over time, more
research is needed to explore the potential reasons why
the largest intervention effects appeared around the
6

6-month follow-up. One explanation could be that psychosocial interventions have the most impact at an early
stage in the cancer survivorship journey when the content is still new. If this was the case, however, findings
at 3 months26 could have been expected to be the most
significant. Because participants were “on their own”
progressing in the app (ie, it was user-driven rather than
driven by provider guidance), however, it could be that
3 months was not enough time and that the 6-month follow-up revealed the benefits of more thoroughly acquired
knowledge, skills, and strategies. A somewhat larger attrition rate in the intervention group compared with the
control group from 3 to 6 months could potentially also
have played a role if, for example, mainly particularly
interested participants remained in the intervention at
6 months. Another factor to consider is that although both
groups appeared to improve somewhat from the baseline
to 3 months, the intervention group continued to improve, whereas the usual-care control group appeared to
experience worsening symptoms from 3 to 6 months. It
is possible that cancer survivors in the intervention group
did in fact experience a sort of buffering effect from the
StressProffen intervention during what may have otherwise been a challenging period in the cancer trajectory for
most participants.
The simple blended care delivery model (ie, 1 introduction session, 10 app-based modules, and 2 follow-up
phone calls) was used not only to ensure assistance should
participants encounter technical issues but also to provide a sense of support throughout the self-management
process. Even this simple form of blended care may have
had an impact because guided eHealth interventions have
been suggested to have better effects than self-guided interventions.20 There was no follow-up contact between
the research team and the participants between 6 and
12 months; if the simple blended care delivery induced
a sense of guidance, this could have contributed to the
more significant findings at 6 months. Another reason
could be that the impact decreased as time progressed,
and this supports the general notion that most interventions show declining impact over time. It should, however, be noted that even though a clear decline in program
use was seen from 6 to 12 months, the impact of the program (ie, acquired knowledge and skills) could still be of
benefit independently of actual app use.
Effect sizes in the current study ranged from small
(<0.2) to moderate (<0.5). The great variation in data,
indicating that some participants may have benefited
more from the intervention than others, may have contributed to the limited study effect sizes. However, small
Cancer  
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TABLE 2. Effects of StressProffen at 6 and 12 Months: Estimated Means From Generalized Linear Models
Intervention Group
(n = 84)

Perceived stress (PSS-14)
Baseline
6 mo
12 mo
Anxiety (HADS-A)
Baseline
6 mo
12 mo
Depression (HADS-D)
Baseline
6 mo
12 mo
Self-regulatory fatigue (SRF-18)
Baseline
6 mo
12 mo
HRQOL (RAND-36)
Physical functioning
Baseline
6 mo
12 mo
Role-physical
Baseline
6 mo
12 mo
Bodily pain
Baseline
6 mo
12 mo
General health
Baseline
6 mo
12 mo
Vitality
Baseline
6 mo
12 mo
Social functioning
Baseline
6 mo
12 mo
Role-emotional
Baseline
6 mo
12 mo
Mental health
Baseline
6 mo
12 mo

Control Group
(n = 88)

M

95% CI

M

95% CI

26.7
21.1
21.5

25.0-28.5
19.2-23.0
19.6-23.5

25.6
25.0
22.7

23.8-27.3
23.2-26.8
20.8-24.5

8.5
6.6
6.3

7.6-9.4
5.6-7.6
5.3-7.3

8.8
8.3
7.5

7.9-9.7
7.4-9.2
6.6-8.5

5.4
3.5
3.8

4.6-6.1
2.7-4.3
3.0-4.6

5.0
5.3
4.5

4.3-5.7
4.5-6.0
3.8-5.3

52.0
47.0
47.8

49.7-54.2
44.6-49.3
45.4-50.2

50.5
50.4
48.4

48.3-52.2
48.2-52.6
46.1-50.6

72.9
79.4
76.2

68.4-77.4
74.5-84.2
71.2-81.2

79.2
76.5
79.2

74.8-83.6
72.0-81.1
74.6-84.0

19.9
40.8
34.4

11.7-28.2
31.6-49.9
25.1-43.8

37.5
33.8
46.3

29.4-45.6
25.5-42.2
37.6-55.0

57.5
66.6
59.2

52.4-62.8
60.8-72.4
53.3-65.1

64.1
59.6
64.4

59.0-69.3
54.3-64.9
58.9-69.9

50.2
52.0
49.5

45.1-55.2
46.6-57.3
44.1-54.9

55.6
52.1
53.9

50.6-60.5
47.0-57.1
48.8-59.0

38.9
50.4
47.4

34.2-43.6
45.3-55.4
42.2-52.5

46.5
46.9
51.5

41.9-51.0
42.2-52.6
46.6-56.3

51.8
68.9
69.9

46.5-57.1
63.1-74.6
64.0-75.8

63.1
63.0
68.0

57.9-68.2
57.7-68.3
62.5-73.5

46.8
64.0
66.4

37.7-55.9
53.9-74.2
56.0-76.8

52.7
53.7
58.3

43.7-61.6
44.5-62.9
48.6-67.9

65.3
74.3
74.9

61.6-69.0
70.3-78.3
70.8-78.9

66.5
66.7
70.0

62.9-70.1
63.0-70.4
66.2-73.8

Between-Group
Differencesa
MD

95% CI

P

Effect Size β

Time-Trend Pb
<.001

–5.1
–2.3

–7.5 to –2.7
–4.8 to 0.1

<.001
.063

0.32
0.14
.111

–1.4
–1.0

–2.5 to –0.3
–2.1 to 0.2

.015
.101

0.19
0.14
.003

–2.1
–1.1

–3.0 to –1.1
–2.0 to –0.1

<.001
.033

0.36
0.19
.002

–4.9
–2.0

–7.2 to –2.5
–4.5 to 0.4

<.001
.102

0.31
0.13
.011

9.1
3.2

2.9 to 15.4
–0.3 to 9.6

.004
.335

0.22
0.06
.001

24.5
5.7

11.4 to 37.6
–7.8 to 19.2

<.001
.406

0.29
0.06
.004

13.6
1.4

5.8 to 21.4
–6.6 to 9.4

.001
.727

0.27
0.03
.075

5.3
1.0

–0.1 to 10.4
–4.5 to 6.5

.053
.719

0.16
0.02
.001

11.1
3.5

5.1 to 17.1
–2.7 to 9.7

<.001
.268

0.28
0.09
<.001

17.1
13.2

9.5 to 24.7
5.3 to 21.0

<.001
.001

0.34
0.26
.070

16.1
14.0

1.0 to 31.2
–1.6 to 29.5

.037
.079

0.16
0.14
.015

8.8
6.1

3.9 to 13.6
1.0 to 11.1

<.001
.018

0.28
0.19

Abbreviations: CI, confidence interval; HADS-A, Hospital Anxiety and Depression Scale–Anxiety; HADS-D, Hospital Anxiety and Depression Scale–Depression;
HRQOL, health-related quality of life; M, estimated mean; MD, estimated mean difference; PSS-14, Perceived Stress Scale; SRF-18, Self-Regulatory Fatigue 18.
Three-month findings have been reported elsewhere (see Børøsund et al26).
a
Between-group differences were computed as the intervention group change from the baseline minus the control group change from the baseline. Negative values
for PSS-14, HADS-A, HADS-D, and SRF-18 and positive values for RAND subscales indicate results in favor of the intervention group.
b
Interactions between time and group (eg, a statistically significant P value indicates that the time trajectories were different for the 2 groups).

to moderate statistical effect sizes are not uncommon for
psychosocial interventions in cancer and still provide evidence of statistical and clinical significance.11,14 The fact
that such effect sizes can be achieved with even minimal
cost and effort via a digital approach further highlights
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the significant potential for the outreach and impact of
digital self-management interventions.
In addition to the longstanding limited availability
of and access to psychosocial interventions for cancer survivors, a failure to meet the psychosocial needs of cancer
7
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Figure 3. Estimated marginal means of (A) perceived stress (PSS-14), (B) anxiety (HADS-A), (C) depression (HADS-D), and (D)
self-regulatory fatigue (SRF-18) for the intervention group (n = 84) and the usual-care control group (n = 88). Higher scores are
indications of higher levels of stress, anxiety, depression, and self-
regulatory fatigue. HADS-
A indicates Hospital Anxiety and
Depression Scale–Anxiety; HADS-D, Hospital Anxiety and Depression Scale–Depression; PSS-14, Perceived Stress Scale; SRF-18,
Self-Regulatory Fatigue 18.

survivors during the recent coronavirus disease 2019 pandemic,17 a pandemic bringing with it an instant need for
new ways to deliver care, has also been indicated. Digital
stress management solutions such as StressProffen may
contribute to solving, or at least limiting, these types of
challenges by providing innovative options for the outreach of effective psychosocial interventions even during
challenging times.
To achieve the intended impact of interventions,
adherence and continued use are vital. With adherence/
completion rates for eHealth interventions sometimes as
low as 20% to 40% (ie, 60%-80% attrition), however, the
potential for intervention evaluation and effect is seriously
compromised, and adherence and attrition surface as major
8

obstacles to the realization of eHealth interventions.21,27,36
In the current study, as many as 68% of the participants
could be considered completers (ie, completing ≥7 of 10
modules within the study period).24,26 Completer status
did, however, not affect outcomes, and this might indicate
that even modest use of the StressProffen program could
potentially have a positive impact.
The current study indicates that even minimal
blended care models can strengthen delivery and the
chance of impact. Future research should explore the extent needed to achieve such an impact. Could 1 phone
call, or a simple introduction by a health care provider, be
enough? Also, such explorations could determine whether
completely user-driven digital self-management programs
Cancer  
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can be effective; if so, this could mean even more simple,
cost-effective health care. Future studies should also aim
to rigorously compare well-established in-person psychosocial interventions for cancer survivors with comparable
digital interventions such as StressProffen.
Limitations

This study has several limitations. First, recruitment allowed for cancer survivors to contact the research team if
they were interested in participation, and it can be assumed
that these participants (41%) were particularly motivated;
this potentially affected study generalizability. Second,
disease status and treatment status were self-
reported
and could not be verified. Third, although a wide variety
of cancer diagnoses were included in the current study,
participants were mainly female, with a majority being
breast cancer survivors. To strengthen generalizability and
clinical utility, future research should aim to improve the
gender balance and include more heterogeneous cancer
survivor populations. Fourth, baseline scores were low to
moderate for the majority of the outcome measures in the
current study. It is possible that enrolling cancer survivors
with higher baseline distress levels (ie, minimal distress
score inclusion criteria) could have resulted in even higher
intervention benefits for the participants. Finally, because
of the access/not-access nature of the intervention, group
allocation could not be blinded. Intervention group participants may, therefore, have anticipated potential effects,
particularly if they were aware of findings from existing
StressProffen publications.24,26
In conclusion, in an RCT, cancer survivors receiving
StressProffen, a digital cognitive-behavioral stress management intervention delivered in a simple blended care
model, compared with usual-care cancer survivor controls,
reported improvements in perceived stress, depression,
self-regulatory fatigue, and HRQOL over a 12-month
time period. Digital stress management interventions
such as StressProffen, built on evidence, with significant
stakeholder involvement in the design and development
process, have the potential to improve outreach and provide easily available and effective psychosocial support for
cancer survivors. This type of care model could be especially effective in meeting distress management guidelines
and accreditation standards in the provision of comprehensive cancer care.
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